BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Wei-Ming Chen, Wayne H-H Sheu, Pei-Chi Tseng, Tzong-Shyuan Lee, Wen-Jane Lee, Pey-Jium Chang, An-Na Chiang, Nicola Amodio. Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by StatinsPLOS ONE 2016; 11(5): e0154672 doi: 10.1371/journal.pone.0154672
2
Yaron Rotman, Arun J Sanyal. Current and upcoming pharmacotherapy for non-alcoholic fatty liver diseaseGut 2017; 66(1): 180 doi: 10.1136/gutjnl-2016-312431
3
Tie Fang, Jianjun Li, Xianjiang Wu. Shenmai injection improves the postoperative immune function of papillary thyroid carcinoma patients by inhibiting differentiation into Treg cells via miR-103/GPER1 axisDrug Development Research 2018; 79(7): 324 doi: 10.1002/ddr.21459
4
H. Wang, L. Liu, X. Liu, M. Zhang, X. Li. Correlation between miRNAs and target genes in response to Campylobacter jejuni inoculation in chickenPoultry Science 2018; 97(2): 485 doi: 10.3382/ps/pex343
5
Tanapa Suksangrat, Phatchariya Phannasil, Sarawut Jitrapakdee. Reviews on Biomarker Studies of Metabolic and Metabolism-Related DisordersAdvances in Experimental Medicine and Biology 2019; 1134: 129 doi: 10.1007/978-3-030-12668-1_7
6
Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, Rocío Montero-Vallejo, Ángela Rojas, Rocío Muñoz-Hernández, Rocío Gallego-Durán, Manuel Romero-Gómez. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysisJournal of Hepatology 2018; 69(6): 1335 doi: 10.1016/j.jhep.2018.08.008
7
Xuefeng An, Hong Quan, Jinhui Lv, Lingyu Meng, Cheng Wang, Zuoren Yu, Jing Han. Serum microRNA as potential biomarker to detect breast atypical hyperplasia and early-stage breast cancerFuture Oncology 2018; 14(30): 3145 doi: 10.2217/fon-2018-0334
8
Qiaozhu Su, Virender Kumar, Neetu Sud, Ram I. Mahato. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosisAdvanced Drug Delivery Reviews 2018; 129: 54 doi: 10.1016/j.addr.2018.01.009
9
Dan Ye, Tianbao Zhang, Guohua Lou, Weiwei Xu, Fengqin Dong, Guoping Chen, Yanning Liu. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patientsLife Sciences 2018; 208: 201 doi: 10.1016/j.lfs.2018.07.029
10
Ruixian Huang, Xiaoyan Duan, Jangao Fan, Guangming Li, Baocan Wang. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver DiseaseBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8690592
11
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
12
Xiaojing Hu, Liyi Chi, Wentao Zhang, Tiao Bai, Wei Zhao, Zhanbin Feng, Hongyan Tian. Down-regulation of the miR-543 alleviates insulin resistance through targeting the SIRT1Biochemical and Biophysical Research Communications 2015; 468(4): 781 doi: 10.1016/j.bbrc.2015.11.032
13
Yu Zhang, Xinghui Sun, Basak Icli, Mark W. Feinberg. Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for TherapyEndocrine Reviews 2017; 38(2): 145 doi: 10.1210/er.2016-1122
14
Hao Lv, Huashan Yang, Yuanrui Wang, Gianpaolo Papaccio. Effects of miR-103 by negatively regulating SATB2 on proliferation and osteogenic differentiation of human bone marrow mesenchymal stem cellsPLOS ONE 2020; 15(5): e0232695 doi: 10.1371/journal.pone.0232695
15
Thomas H. Thatcher, Collynn F. Woeller, Juilee Thakar, Atif Khan, Philip K. Hopke, Matthew Ryan Smith, Karan Uppal, Douglas I. Walker, Young-Mi Go, Dean P. Jones, Pamela L. Krahl, Timothy M. Mallon, Patricia J. Sime, Richard P. Phipps, Mark J. Utell. Analysis of Postdeployment Serum Samples Identifies Potential Biomarkers of Exposure to Burn Pits and Other Environmental HazardsJournal of Occupational and Environmental Medicine 2019; 61: S45 doi: 10.1097/JOM.0000000000001715
16
Linyuan Shen, Mailin Gan, Qiang Li, Jinyong Wang, Xuewei Li, Shunhua Zhang, Li Zhu. MicroRNA-200b regulates preadipocyte proliferation and differentiation by targeting KLF4Biomedicine & Pharmacotherapy 2018; 103: 1538 doi: 10.1016/j.biopha.2018.04.170
17
Siti Aishah Sulaiman, Nor I. A. Muhsin, Rahman Jamal. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver DiseaseFrontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00279
18
Xiao Lin Liu, Hai Xia Cao, Jian Gao Fan. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver diseaseJournal of Digestive Diseases 2016; 17(11): 708 doi: 10.1111/1751-2980.12408
19
Matthew J Watt, Paula M Miotto, William De Nardo, Magdalene K Montgomery. The Liver as an Endocrine Organ—Linking NAFLD and Insulin ResistanceEndocrine Reviews 2019; 40(5): 1367 doi: 10.1210/er.2019-00034
20
Bingguo Luan, Caixia Sun. MiR-138-5p affects insulin resistance to regulate type 2 diabetes progression through inducing autophagy in HepG2 cells by regulating SIRT1Nutrition Research 2018; 59: 90 doi: 10.1016/j.nutres.2018.05.001
21
Q. Ling, H. Xie, J. Li, J. Liu, J. Cao, F. Yang, C. Wang, Q. Hu, X. Xu, S. Zheng. Donor Graft MicroRNAs: A Newly Identified Player in the Development of New-onset Diabetes After Liver TransplantationAmerican Journal of Transplantation 2017; 17(1): 255 doi: 10.1111/ajt.13984
22
Monica J. Hubal, Evan P. Nadler, Sarah C. Ferrante, Matthew D. Barberio, Jung-Hyuk Suh, Justin Wang, G. Lynis Dohm, Walter J. Pories, Michelle Mietus-Snyder, Robert J. Freishtat. Circulating adipocyte-derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypassObesity 2017; 25(1): 102 doi: 10.1002/oby.21709
23
Andrea Jaeger, Lukas Zollinger, Christoph H. Saely, Axel Muendlein, Ioannis Evangelakos, Dimitris Nasias, Nikoleta Charizopoulou, Jonathan D. Schofield, Alaa Othman, Handrean Soran, Dimitris Kardassis, Heinz Drexel, Arnold von Eckardstein. Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitusScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32274-9
24
Yu Zhang, Xinghui Sun, Basak Icli, Mark W. Feinberg. Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for TherapyEndocrine Reviews 2017; 2017(1): 1 doi: 10.1210/er.2016-1122.2017.1.test
25
Chenggui Miao, Zhongwen Xie, Jun Chang. Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential DirectionsBiochemical Genetics 2018; 56(5): 423 doi: 10.1007/s10528-018-9870-9
26
Yuxiang Huang, Yuxiang Yan, Weicheng Xv, Ge Qian, Chijian Li, Hequn Zou, Yongqiang Li. A New Insight into the Roles of MiRNAs in Metabolic SyndromeBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/7372636
27
Zhichao Liu, Yuping Wang, Jürgen Borlak, Weida Tong. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different gradesScientific Reports 2016; 6(1) doi: 10.1038/srep23709